Patents by Inventor Shigemichi Gunji

Shigemichi Gunji has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6986990
    Abstract: T cells from multiple subjects who showed different cedar pollen specific IgE titers were prepared before and after cedar pollen dispersal, and differential display analysis was performed to screen for pollen antigen responsive genes. As a result, a novel gene was successfully isolated whose expression is significantly higher in subjects with high cedar pollen specific IgE titer. The inventors have found that it is possible to use this gene to test for an allergic disease and to screen for candidate compounds for therapeutic drugs for an allergic disease.
    Type: Grant
    Filed: April 26, 2000
    Date of Patent: January 17, 2006
    Assignee: Genox Research, Inc.
    Inventors: Takeshi Nagasu, Yuji Sugita, Tomoko Fujishima, Tadahiro Oshida, Masaya Obayashi, Shigemichi Gunji, Izumi Obayashi, Yukiho Imai, Nei Yoshida, Kaoru Ogawa, Keiko Matsui
  • Publication number: 20040234969
    Abstract: CYP1B1 was obtained as a gene whose expression levels in mononuclear cells greatly differs between a steroid responder group and a poorly steroid responder group of atopic dermatitis patients. CYP1B1 is a gene whose expression levels are reduced in mononuclear cells of the poorly steroid responder group. The present invention provides a method for testing steroid responsiveness and a method of screening for a compound that is useful in improving steroid responsiveness using the expression level of this gene in biological samples as an indicator.
    Type: Application
    Filed: May 19, 2004
    Publication date: November 25, 2004
    Inventors: Sugita Yuji, Masayuki Heishi, Shinji Kagaya, Shigemichi Gunji, Hiroshisa Saito
  • Publication number: 20040197786
    Abstract: RING6 and HLA-DMB are described herein as genes whose expression levels in mononuclear cells greatly differ between a steroid responder group and a poor steroid responder group in atopic dermatitis patients. Specifically, the expression levels of the RING6 and HLA-DMB genes were demonstrated to be reduced in steroid-responsive patients. Using the expression level of such genes in biological samples as markers of steroid responsiveness, the present invention provides a method of testing for steroid responsiveness and a method of screening for compounds that may be used to improve steroid responsiveness.
    Type: Application
    Filed: May 25, 2004
    Publication date: October 7, 2004
    Inventors: Yuji Sugita, Masayuki Heishi, Shinji Kagaya, Shigemichi Gunji, Gozoh Tsujimoto
  • Publication number: 20040185459
    Abstract: A probe is utilized in the hybridization with a natural nucleic acid to form a double strand. The probe contains a cytosine derivative which specifically binds to guanine by forming two hydrogen bonds with the guanine nucleotide and/or a guanine derivative which specifically binds to cytosine by forming two hydrogen bonds with the cytosine nucleotide. This enables a large number of hybridization reactions to be carried out at once under uniform conditions.
    Type: Application
    Filed: March 24, 2004
    Publication date: September 23, 2004
    Inventors: Masami Otsuka, Tetsuo Yamasaki, Shigemichi Gunji, Fujio Yu, Katsuaki Kikuchi, Toshitaka Uragaki